InvestorsHub Logo
Followers 2
Posts 1472
Boards Moderated 0
Alias Born 07/20/2016

Re: ubmmg post# 68063

Wednesday, 05/16/2018 10:46:21 AM

Wednesday, May 16, 2018 10:46:21 AM

Post# of 108192
In talking with IR in the past, I would ask about the sentiment for the combo data and they were always careful to say "if" the data is good it could be a game-changer. Checkpoint inhibitors, in the past, did not show much activity in prostate cancer so even moderate success may pique Merck's interest for a deal. We'll know soon enough. GLTA!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News